SCHEMBL19081806

SCHEMBL19081806

c1ccc2c(-c3c4ccccc4c(-c4cc5c(sc6ccc7ccccc7c65)c5oc6ccccc6c45)c4ccccc34)cccc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ALOX5 P09917 2/20 0.34
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32
MAPT P10636 3/20 0.32
AHR P35869 3/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
CYP2C9 P11712 2/20 0.32
CYP2C19 P33261 2/20 0.32
TP53 P04637 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
NQO1 P15559 1/20 0.32
NQO2 P16083 1/20 0.32
KDM4E B2RXH2 2/20 0.31
ALDH1A1 P00352 2/20 0.31
RAB9A P51151 2/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081940 0.93 TDP1 (0.33) TDP1L3MBTL1ALOX5
SCHEMBL19081848 0.87 TDP1 (0.32) TDP1L3MBTL1AHRCYP2C9CYP2C19
SCHEMBL19082046 0.85 ALOX5 (0.38) TDP1L3MBTL1ALOX5ESR1ESR2
SCHEMBL19081791 0.84 TDP1 (0.36) TDP1L3MBTL1ESR1ESR2MAPT
SCHEMBL19082045 0.82 ALOX5 (0.38) TDP1L3MBTL1ALOX5ESR1ESR2
SCHEMBL19081956 0.82 ALOX5 (0.33) TDP1L3MBTL1ALOX5AHRCYP1A2
SCHEMBL19081775 0.81 ALOX5 (0.34) TDP1L3MBTL1ALOX5ESR1ESR2
SCHEMBL19081935 0.81 TDP1 (0.34) TDP1L3MBTL1MAPTAHRMEN1
SCHEMBL19082047 0.81 TDP1 (0.36) TDP1L3MBTL1ALOX5MAPTMEN1
SCHEMBL17944479 0.81 TDP1 (0.44) TDP1L3MBTL1MAPTAHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 TDP1 2322/4885L3MBTL1 1245/4885ALOX5 1939/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 TDP1 2322/4885L3MBTL1 1245/4885ALOX5 1939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.